AIDA BERGSEN TAKI VE EL SANATLARI URETIM LTD.STI – Trademark Portfolio

Entity Type: 16

AIDA BERGSEN TAKI VE EL SANATLARI URETIM LTD.STI holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include AIDA BERGSEN.

Emin Sinan Mah., Tasdirek Çesmesi Sk.,

Altunbüken Pasaji No:6/54 Fatih - Istanb

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

AIDA BERGSEN TAKI VE EL SANATLARI URETIM LTD.STI's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

14
Jewelry (2 filings)

Precious metals and their alloys; jewellery, precious stones; horological instruments

Frequently Asked Questions

How many trademarks does AIDA BERGSEN TAKI VE EL SANATLARI URETIM LTD.STI have?

AIDA BERGSEN TAKI VE EL SANATLARI URETIM LTD.STI has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered.

What trademark classes does AIDA BERGSEN TAKI VE EL SANATLARI URETIM LTD.STI file in?

AIDA BERGSEN TAKI VE EL SANATLARI URETIM LTD.STI files trademarks across 1 Nice Classification class. The most active classes are Class 14 (Jewelry). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.

What are AIDA BERGSEN TAKI VE EL SANATLARI URETIM LTD.STI's most well-known trademarks?

AIDA BERGSEN TAKI VE EL SANATLARI URETIM LTD.STI's registered trademark portfolio includes well-known marks such as AIDA BERGSEN. These are among 1 currently registered trademark in the portfolio.

What is AIDA BERGSEN TAKI VE EL SANATLARI URETIM LTD.STI's trademark registration success rate?

AIDA BERGSEN TAKI VE EL SANATLARI URETIM LTD.STI has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.